SimonMed Imaging Partners with Lunit for AI Breast Cancer Detection
SimonMed Imaging has partnered with Lunit to enhance breast cancer detection using advanced AI technology, announced in a press release. This collaboration will integrate Lunit INSIGHT DBT, combined with Volpara Analytics, into SimonMed's Personalized Breast Cancer Detection service across its network of over 170 centers in the United States.
The AI solution, trained on millions of images, is designed to detect subtle signs of breast cancer, improving both sensitivity and specificity. This integration aims to provide patients with a precise, personalized, and data-driven screening experience, supported by SimonMed's team of over 200 subspecialty-trained radiologists.
Dr. Sean Raj, Chief Innovation Officer at SimonMed Imaging, emphasized the importance of this partnership in offering the most advanced mammogram experience available today. The initiative reflects SimonMed's commitment to early detection and proactive patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 20 IDC Names ZS a Leader in Life Sciences Evidence Services Sep 20 Brainomix Selected for UK Future Fifty Programme Sep 19 Rutgers and RWJBarnabas Health Launch AWS Health Innovation Hub Sep 19 Vetology Rebuilds 94 Veterinary Radiology AI Classifiers Sep 19 NAVER D2SF Backs ImpriMed in $10 Million Bridge RoundLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
NYU Langone AI Uses Multiple 3D Mammograms to Predict Breast Cancer Risk
Trust AI Integrates VELMENI Dental Imaging With Isaac PracticeOS
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Daily AI Brief: the AI news that matters, in your inbox.